VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $21,536,000 | +2.6% | 1,502,850 | +23.9% | 0.75% | +3.3% |
| Q2 2017 | $20,981,000 | +1658.7% | 1,212,800 | +18028.6% | 0.72% | +1753.8% |
| Q3 2015 | $1,193,000 | -19.7% | 6,690 | 0.0% | 0.04% | -7.1% |
| Q2 2015 | $1,486,000 | +9.9% | 6,690 | -1.7% | 0.04% | +7.7% |
| Q1 2015 | $1,352,000 | +28.6% | 6,805 | -7.4% | 0.04% | +25.8% |
| Q4 2014 | $1,051,000 | -14.8% | 7,345 | -21.9% | 0.03% | -20.5% |
| Q3 2014 | $1,233,000 | +4.0% | 9,400 | 0.0% | 0.04% | +8.3% |
| Q2 2014 | $1,186,000 | -28.3% | 9,400 | -25.1% | 0.04% | -33.3% |
| Q1 2014 | $1,654,000 | +1.6% | 12,550 | -9.5% | 0.05% | -29.9% |
| Q4 2013 | $1,628,000 | +23.1% | 13,870 | +9.5% | 0.08% | +6.9% |
| Q3 2013 | $1,322,000 | +21.2% | 12,670 | 0.0% | 0.07% | +12.5% |
| Q2 2013 | $1,091,000 | – | 12,670 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |